These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 38724687)

  • 1. Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.
    Beigi YZ; Lanjanian H; Fayazi R; Salimi M; Hoseyni BHM; Noroozizadeh MH; Masoudi-Nejad A
    Mol Biomed; 2024 May; 5(1):17. PubMed ID: 38724687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.
    Bustamante P; Tsering T; Coblentz J; Mastromonaco C; Abdouh M; Fonseca C; Proença RP; Blanchard N; Dugé CL; Andujar RAS; Youhnovska E; Burnier MN; Callejo SA; Burnier JV
    J Exp Clin Cancer Res; 2021 Jun; 40(1):196. PubMed ID: 34134723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.
    Soltysova A; Sedlackova T; Dvorska D; Jasek K; Chokhachi Baradaran P; Horvathova Kajabova V; Demkova L; Buocikova V; Kurucova T; Lyskova D; Furdova A; Minarik G; Babal P; Dankova Z; Smolkova B
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Molecular and Genetic Research on Uveal Melanoma.
    Fuentes-Rodriguez A; Mitchell A; Guérin SL; Landreville S
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.
    Sementsov M; Ott L; Kött J; Sartori A; Lusque A; Degenhardt S; Segier B; Heidrich I; Volkmer B; Greinert R; Mohr P; Simon R; Stadler JC; Irwin D; Koch C; Andreas A; Deitert B; Thewes V; Trumpp A; Schneeweiss A; Belloum Y; Peine S; Wikman H; Riethdorf S; Schneider SW; Gebhardt C; Pantel K; Keller L
    EMBO Mol Med; 2024 Jul; 16(7):1560-1578. PubMed ID: 38898234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
    de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
    Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future perspectives of uveal melanoma blood based biomarkers.
    Beasley AB; Chen FK; Isaacs TW; Gray ES
    Br J Cancer; 2022 Jun; 126(11):1511-1528. PubMed ID: 35190695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell RNA-sequencing in uveal melanoma: advances in heterogeneity, tumor microenvironment and immunotherapy.
    Tang S; Zhang Y; Huang S; Zhu T; Huang X
    Front Immunol; 2024; 15():1427348. PubMed ID: 38966635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities.
    Liebs S; Eder T; Klauschen F; Schütte M; Yaspo ML; Keilholz U; Tinhofer I; Kidess-Sigal E; Braunholz D
    Oncogene; 2021 Aug; 40(33):5204-5212. PubMed ID: 34230613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of Aqueous Humor as a Liquid Biopsy for Uveal Melanoma.
    Im DH; Peng CC; Xu L; Kim ME; Ostrow D; Yellapantula V; Bootwalla M; Biegel JA; Gai X; Prabakar RK; Kuhn P; Hicks J; Berry JL
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
    Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
    Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.
    Salvianti F; Massi D; De Giorgi V; Gori A; Pazzagli M; Pinzani P
    Cancer Biomark; 2019; 26(3):271-279. PubMed ID: 31524142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current molecular and clinical insights into uveal melanoma (Review).
    Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients.
    Tura A; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S; Lüke J
    Pigment Cell Melanoma Res; 2016 Sep; 29(5):583-9. PubMed ID: 27390171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
    Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
    Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic insights into uveal melanoma.
    Sharma A; Stei MM; Fröhlich H; Holz FG; Loeffler KU; Herwig-Carl MC
    Clin Genet; 2018 May; 93(5):952-961. PubMed ID: 28902406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles of microRNAs and their implications in uveal melanoma.
    Yang C; Wang Y; Hardy P
    Cell Mol Life Sci; 2021 Jan; 78(2):545-559. PubMed ID: 32783068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring.
    Kamińska P; Buszka K; Zabel M; Nowicki M; Alix-Panabières C; Budna-Tukan J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.